Related Experiment Video
Updated: Nov 24, 2025

Application of Lucilia sericata Larvae in Debridement of Pressure Wounds in Outpatient Settings
Published on: December 4, 2021
Impact of a Swiss pressure ulcer prevention breakthrough collaborative
Anthony Staines1,2, Isabelle Amherdt1, Bernard Burnand3
1Patient Safety and Quality of Care Programme, Vaud Hospital Federation, Prilly, Switzerland.
A collaborative effort significantly reduced hospital-acquired pressure ulcers by nearly half. This initiative improved adherence to prevention protocols, enhancing patient care and quality of life.
Area of Science:
- Healthcare Improvement Science
- Patient Safety Research
- Clinical Quality Management
Background:
- Hospital-acquired pressure ulcers significantly impair patient quality of life.
- In Switzerland, 4% of patients develop hospital-acquired pressure ulcers.
- A Breakthrough Collaborative aimed to reduce these ulcers by 50%.
Purpose of the Study:
- To assess the effectiveness of a multimodal intervention in reducing hospital-acquired pressure ulcers.
- To evaluate the impact of a collaborative improvement approach on patient safety.
Main Methods:
- A multimodal intervention including risk assessment, prevention bundles, e-learning, and patient engagement was implemented over 18 months.
- Six Swiss hospitals participated, monitoring compliance and using a safety calendar for data tracking.
- Interventions were deployed across all wards except obstetrics and gynaecology.
Main Results:
- Compliance with Braden risk assessments increased from 39% to 61% (P < .001).
- Prevention bundle compliance rose from 2% to 30% (P < .001).
- Hospital-acquired pressure ulcers decreased by 49% (P < .001), preventing 1124 new cases.
Conclusions:
- A multimodal improvement approach, coupled with measurement and feedback, significantly reduced hospital-acquired pressure ulcers.
- The collaborative achieved a statistically and clinically significant reduction, nearing the 50% goal.
- Improved compliance to best practices was a key factor in the observed reduction.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Peripheral Artery Disease III: Interprofessional Care
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Chronic Pancreatitis II: Collaborative Care
Assessment:
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

